Astronics (ATRO) Q2 2024 earnings summary

Executive summary

• Q2 2024 sales grew 14% year-over-year to $198.1 million, with strong demand, new program wins, and both Aerospace and Test Systems segments contributing to growth.

• Net income for Q2 2024 was $1.5 million, a turnaround from a $12.0 million net loss in Q2 2023, with operating income at $7.6 million.

• Adjusted EBITDA increased 28% to $20.2 million (10.2% margin), and gross margin improved to 20.9%.

• Bookings reached $219 million, resulting in a record backlog of $633.4 million and a book-to-bill ratio of 1.11.

• Aerospace segment, nearly 90% of sales, delivered solid growth and margin improvement; Test Systems segment underwent restructuring and a reset.

Financial highlights

• Q2 2024 consolidated sales were $198.1 million, up 13.6% year-over-year; YTD sales reached $383.2 million, up 15.8%.

• Adjusted EBITDA margin rose to 10.2% from 9.1% year-over-year, and operating margin improved to 3.8% from 1.4% in Q2 2023.

• Gross margin expanded to 20.9% from 18.7% in Q2 2023.

• Q2 net income was $1.5 million ($0.04 per diluted share), compared to a net loss of $12.0 million in Q2 2023.

• Bookings reached $219 million, backlog at $633.4 million, with $402 million scheduled to ship in H2 2024.

Outlook and guidance

• Full-year 2024 revenue guidance raised to $780–$800 million, a 15% increase over 2023 at the midpoint.

• Q3 2024 revenue forecasted at $195–$205 million, with continued top-line growth expected in Q4.

• Adjusted EBITDA margins in the mid-teens are targeted by year-end, contingent on stable operations and no further one-time adjustments.

• Capital expenditures for 2024 are planned at $17–$22 million.

• Significant improvement in cash flow anticipated in H2 2024 as working capital normalizes.